Hint mode is switched on Switch off

HELX - Franklin Genomic Advancements ETF (USD) (US35473P5200)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

FIND, SAVE & TRACK INVESTMENTS WITH CBONDS WATCHLIST

With Cbonds Watchlist you can always stay updated on your investments to make conscious decisions!

Watchlist
You need to request access
 
(%)
US35473P5200
HELX ISIN
Exchange Traded Funds (ETF)
Type of fund
Franklin Templeton Investments
Provider
40.53 USD
NAV per Share | 14/08/2026
25/02/2020
Inception Date
1 times per year
Dividend payments
CEOJLS
CFI
HELX
Ticker
Formed
Status
Equity
Investment category
Biotech
Sector
USA
Investor locations
Russell 3000 Index
Benchmark
0.5 %
Total Cost Ratio
30.4 mln USD
Fund NAV | 14/08/2026
30.4 mln USD
Share Class NAV | 14/08/2026
No
UCITS
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in

Yield on 14/08/2026, Cboe BZX Exchange

  • YTD
    -10.83 %
  • 1M
    -6.62 %
  • 3M
    -7.6 %
  • 6M
    -7.55 %
  • 1Y
    24.21 %
  • 3Y
    9 %
  • 5Y
    -21.11 %
  • 10Y
    -
At the price on the exchange, taking into account income payments

Latest data on
Add to compare

Quotes (HELX)

Explore the most comprehensive database

1 000 000

bonds

100 000

stocks

175 910

ETF & Funds

100 000

indices

Track your portfolio in the most efficient way

  • Bond Search
  • Watchlist
  • Excel ADD-IN
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 1 000 000 bonds, 100 000 stocks, 100 000 indices, 17 000 ETF and 150 000 Mutual Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 1M bonds, 100K stocks, 100K indices, 17K ETF and 150K Mutual Funds
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Price dynamics

HELX profile

The Franklin Genomic Advancements ETF (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in USA. The Franklin Templeton Investments fund’s base currency is USD and the share class was registered 25.02.2020 with unique ISIN - US35473P5200. Main exchange is Cboe BZX Exchange and ticker symbol is HELX. The total expense ratio is 0.5%. The Franklin Genomic Advancements ETF (USD) pays dividends 1 time(s) per year.

Structure HELX on 14/08/2026

Paper Value
GUARDANT HEALTH INC GH 9.38%
NATERA INC NTRA 8.39%
KRYSTAL BIOTECH INC KRYS 5.57%
ADAPTIVE BIOTECHNOLOGIES ADPT 4.53%
LIGAND PHARMACEUTICALS LGND 4.24%
BRIDGEBIO PHARMA INC BBIO 3.7%
TWIST BIOSCIENCE CORP TWST 3.54%
UNITED THERAPEUTICS CORP UTHR 3.19%
TRAVERE THERAPEUTICS INC TVTX 2.96%
ELI LILLY & CO LLY 2.96%
VERTEX PHARMACEUTICALS IN VRTX 2.75%
SAMSUNG BIOLOGICS CO LTD 207940 2.7%
CORTEVA INC CTVA 2.47%
MEDPACE HOLDINGS INC MEDP 2.31%
REGENERON PHARMACEUTICALS REGN 2.28%
ASTRAZENECA PLC AZN 2.19%
NEUROCRINE BIOSCIENCES IN NBIX 1.65%
REPLIGEN CORP RGEN 1.56%
CHARLES RIVER LABORATORIE CRL 1.54%
TEMPUS AI INC-CL A TEM 1.5%
ARGENX SE ARGX 1.47%
PRAXIS PRECISION MEDICINE PRAX 1.38%
CAREDX INC CDNA 1.28%
PTC THERAPEUTICS INC PTCT 1.27%
VERACYTE INC VCYT 1.27%
STOKE THERAPEUTICS INC STOK 1.25%
BIONTECH SE-ADR BNTX 1.2%
JAZZ PHARMACEUTICALS PLC JAZZ 1.12%
INSMED INC INSM 1.11%
GRAIL INC GRAL 1.07%
REVOLUTION MEDICINES INC RVMD 1.03%
IQVIA HOLDINGS INC IQV 1%
CRISPR THERAPEUTICS AG CRSP 0.95%
ANAPTYSBIO INC ANAB 0.88%
SARTORIUS AG-VORZUG SRT3 0.88%
THERMO FISHER SCIENTIFIC TMO 0.87%
CADENCE DESIGN SYS INC CDNS 0.83%
HINGE HEALTH INC-A HNGE 0.73%
FIRST TRACKS BIOTHERAPEUT TRAX 0.73%
BEAM THERAPEUTICS INC BEAM 0.71%
AXSOME THERAPEUTICS INC AXSM 0.7%
AGILENT TECHNOLOGIES INC A 0.64%
DANAHER CORP DHR 0.6%
GENMAB A/S -SP ADR GMAB 0.54%
QIAGEN N.V. — 0.52%
CELCUITY INC CELC 0.49%
ROIVANT SCIENCES LTD ROIV 0.49%
VERADERMICS INC MANE 0.47%
COGENT BIOSCIENCES INC COGT 0.46%
MINERALYS THERAPEUTICS IN MLYS 0.46%
RHYTHM PHARMACEUTICALS IN RYTM 0.43%
ARCUTIS BIOTHERAPEUTICS I ARQT 0.41%
KINIKSA PHARMACEUTICALS I KNSA 0.4%
BRISTOL-MYERS SQUIBB CO BMY 0.36%
BIO-RAD LABORATORIES-A BIO 0.3%
TARSUS PHARMACEUTICALS IN TARS 0.28%
BEONE MEDICINES LTD-ADR ONC 0.28%
ULTRAGENYX PHARMACEUTICAL RARE 0.26%
NEUROGENE INC NGNE 0.25%
LIQUIDIA CORP LQDA 0.23%
TG THERAPEUTICS INC TGTX 0.22%
MODERNA INC MRNA 0.22%
SAMSUNG EPISHOLDINGS CO L 0126Z0 0.18%
GENEDX HOLDINGS CORP WGS 0.16%
ALNYLAM PHARMACEUTICALS I ALNY 0.11%
IONIS PHARMACEUTICALS INC IONS 0.1%
OMNIAB INC - 15.00 EARNOU 2200964 0%
OMNIAB INC - 12.5 EARNOUT 2200963 0%
Net Current Assets — 0%
CASH — 0%
Other - %

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Other ETF & Funds from this provider

Similar ETF & Funds

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} mln
    NAV
    {{ item.expense_ratio }}
    Total Cost Ratio
Registration is required to get access.